GSK-232802

N/A

Report date: 2025/04/24 16:16:54

NME

Base Information

Drug NameGSK-232802

Drug Alias NameGSK-232802

ClassificationSmall molecules

Mechanisms of ActionEstrogen receptors modulators

TargetsEstrogen receptors

Therapy Area/IndicationsVasomotor symptom

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsVasomotor symptom

Other Information

ATC CodeN/A

Related LinksN/A